SYN1

SYN1 encodes Synapsin I, a presynaptic phosphoprotein that governs the size, clustering, and mobility of the synaptic vesicle pool and thereby shapes both synchronous and asynchronous neurotransmitter release at excitatory and inhibitory terminals (PMID:21441247, PMID:23406870, PMID:28973667). Disease-associated mutations dissect these functions by domain: D-domain mutations (A51G, A550T, T567A, Q555X) found in autism/epilepsy patients fail to rescue vesicle pool size and trafficking defects in Syn1 knockout neurons, with the Q555X nonsense allele additionally abolishing MAPK/Erk phosphorylation and disrupting neurite outgrowth, and A550T/T567A impairing targeting to nerve terminals (PMID:21441247). Q555X produces a coherent network phenotype—reduced readily releasable pool and release probability driving diminished synchronous release alongside elevated asynchronous release, altered short-term plasticity, and overall hyperexcitability (PMID:23406870)—while the B-domain S79W mutation, in a region recognizing curved membranes, causes somatic accumulation of clear vesicles, excess vesicle clustering, and strongly reduced vesicle mobility (PMID:28973667). Vesicular anchoring and GABA release are tuned by phosphorylation at Ser-553, which is negatively regulated by Cdk5 (PMID:35723394). SYN1 transcription is controlled by Sp1/SP1 binding to GC-box promoter sites and by Foxp2, with repression imposed by REST and CpG methylation of the Sp1 sites (PMID:23250796, PMID:39561537, PMID:31545395). These regulatory and trafficking activities place Synapsin I at the center of presynaptic vesicle dynamics underlying epilepsy, autism, and intellectual disability (PMID:21441247, PMID:23406870).

1. 2011 High

   Establishing whether patient SYN1 D-domain variants are functionally pathogenic, this work showed they fail to restore vesicle pool and trafficking in a KO rescue system where wild-type SynI fully reverts the phenotype, linking specific mutations to defined cell-biological defects.

   Evidence Lentiviral expression of human WT and mutant SYN1 in SynI KO neurons with vesicle trafficking, phosphorylation, terminal targeting, and neurite outgrowth assays

   PMID:21441247

   Open questions at the time

   • Does not resolve how D-domain loss mechanistically uncouples vesicle anchoring from MAPK/Erk phosphorylation
   • Targeting defect of A550T/T567A not traced to a binding partner
2. 2013 High

   To determine how the Q555X mutation produces epilepsy, this work dissected its opposing effects on excitatory versus inhibitory synapses, establishing that imbalanced synchronous/asynchronous release generates network hyperexcitability.

   Evidence Patch-clamp electrophysiology, electron microscopy, and multi-electrode array recordings in SynI KO neurons expressing WT or Q555X SynI

   PMID:23406870

   Open questions at the time

   • Molecular basis for the excitatory-vs-inhibitory divergence not defined
   • Does not establish how loss of phosphorylation translates to altered release probability
3. 2017 High

   Probing the B-domain's role in membrane curvature recognition, the S79W mutation was shown to disrupt vesicle mobility and clustering and to cause somatic vesicle accumulation, linking this domain to vesicle dispersion and trafficking distinct from D-domain defects.

   Evidence Expression of human S79W SynI in Syn1 KO neurons with immunocytochemistry, electrophysiology, and live imaging of vesicle mobility

   PMID:28973667

   Open questions at the time

   • Direct demonstration of altered curved-membrane binding by S79W not shown
   • Mechanism connecting reduced mobility to increased spontaneous excitatory events unresolved
4. 2012 High

   Addressing how SYN1 expression is controlled during neuronal differentiation, this work established a Sp1-activation/REST-repression axis on GC-box promoter sites with CpG methylation as an added repressive layer.

   Evidence ChIP, luciferase reporters, and Sp1/REST knockdown/overexpression with methylation analysis in Neuro2a cells

   PMID:23250796

   Open questions at the time

   • In vivo relevance of methylation-based repression not tested
   • Does not connect transcriptional output to synaptic phenotypes
5. 2014 Medium

   Identifying an additional transcriptional regulator, Foxp2 was shown to bind the SYN1 promoter and drive expression, with miR-134-5p suppressing Foxp2 to reduce SYN1 in a vascular dementia model.

   Evidence ChIP-qPCR, dual luciferase assay, western blotting, and miR-134-5p antagomir injection in vascular dementia rats

   PMID:31545395

   Open questions at the time

   • Single lab; reciprocal validation of the Foxp2–SYN1 axis limited
   • Direct functional consequence on vesicle dynamics not assessed
6. 2021 Medium

   To link kinase signaling to inhibitory transmission, Cdk5 was identified as a negative regulator of SYN1 Ser-553 phosphorylation, with reduced p-SYN1(Ser-553) lowering GABA release.

   Evidence In vivo and in vitro Cdk5 inhibitor/activator studies with western blotting for p-SYN1(Ser-553) and GABA release measurements, MEK inhibitor controls

   PMID:35723394

   Open questions at the time

   • Single lab; direct Cdk5 phosphorylation of SYN1 not reconstituted
   • Causal chain from Calpain-p25-Cdk5 to vesicular anchoring inferred, not directly imaged
7. 2024 Medium

   Extending SP1 regulation to a pathological context, SP1 was shown to bind the SYN1 promoter and upregulate it, with SYN1 knockdown ameliorating brain injury in intracerebral hemorrhage models.

   Evidence JASPAR prediction, ChIP, luciferase reporters, si-SYN1 and SP1 overexpression in PC12 cells, and intracerebroventricular si-SYN1 in ICH rats

   PMID:39561537

   Open questions at the time

   • Single lab; mechanism by which elevated SYN1 promotes neuronal damage not defined
   • Relationship to canonical presynaptic SYN1 function in damage context unclear

• How phosphorylation state at distinct sites integrates with domain-specific membrane and vesicle interactions to set the balance of synchronous versus asynchronous release in vivo remains unresolved.
• No structural model linking B-domain/D-domain mutations to molecular interactions
• Substrate-level reconstitution of Cdk5 phosphorylation of SYN1 lacking
• Integration of transcriptional regulators with synaptic output not mapped